![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, April 22, 2014 10:51:10 AM
From a strictly technical standpoint, the SP was high w/o news. Even after today's fall, RSI still hangs above 30. So it is a hold for me as I still see Titan as a monopoly buster. Any economics professor will tell you something like an ISRG has peaked. Their legal and labor overhead is too high to offer something reasonably less expensive than their current model line. With reimbursements as they are, outpatient clinics need a mobile unit that doesn't break the bank. This is where Titan slips in to take a portion of that market share.
Long and strong (and sees <$1.70 as an easy technical buying opportunity). Don't let the ISRG trolls run this board. They'll be fortunate to see 520 (omg 20% return) in this overpriced biotech/tech bubble. Titan, on the other hand, offers sustainability, and will weather any sort of bubble as more ISRG shareholders leave to find a new home here.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM